Chief Scientific Officer Xiaokui Zhang Profiled in Insights Care Magazine

Our Chief Scientific Officer, Xiaokui Zhang, PhD, was profiled in the Insights Care article titled, “Xiaokui Zhang: Nurturing Healthcare Through Innovative Leadership.”

The article can be found here:

Aspen Neuroscience does not make determination on patient eligibility for clinical trials and all trial related enrollment and eligibility decisions are made by clinical trial sites under the direction of a Principal Investigator. ANPD001 is investigational and is not yet approved by the FDA. At this time, Aspen Neuroscience does not offer or participate in compassionate use or expanded access programs for ANPD001.